Sequelae of poliomyelitis

AB1_SEQULAE_POLIO

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — B91 Hospital discharge: ICD-9 — 138 Hospital discharge: ICD-8 — 04[4] Cause of death: ICD-10 — B91 Cause of death: ICD-9 — 138 Cause of death: ICD-8 — 04[4] 2 out of 7 registries used, show all original rules.	286
4. Check minimum number of events None	286
5. Include endpoints None	286
6. Filter based on genotype QC (FinnGen only)	270

Control definitions (FinnGen only)

Control exclude: AB1_SEQULEAE_OF_INFECTIONS_AND_PARASITES

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF5

NAME	AB1_SEQULAE_POLIO
CONTROL_EXCLUDE	AB1_SEQULEAE_OF_INFECTIONS_AND_PARASITES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	B91
HD_ICD_9	138
HD_ICD_8	04[4]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	B91
COD_ICD_9	138
COD_ICD_8	04[4]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Sequelae of poliomyelitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	3267	1689	1520
Only index persons	2365	1316	1049
Unadjusted period prevalence (%)
Whole population	0.05	0.05	0.04
Only index persons	0.04	0.05	0.04
Median age at first event (years)
Whole population	58.93	58.69	59.11
Only index persons	57.84	57.31	58.50

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	270	127	143
Unadjusted period prevalence (%)	0.06	0.05	0.07
Median age at first event (years)	59.52	57.81	61.04

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
286: Matched controls
2860

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

B91

ICD-10 Finland

Sequelae of poliomyelitis

4503599627370496.0

307.7

250

1380A

ICD-9 Finland

Late effects of acute poliomyelitis[SEQUELAE POLIOMYELITIDIS]

+∞

80.0

N70

ICPC

Poliomyelitis

+∞

59.5

04499

ICD-8 Finland

Late effects of actue poliomyelitis

+∞

57.2

L28

ICPC

Limited function/disability (L)

3.7

23.6

108

407

SPAT1229

SPAT

Assessment of need for aid

4.5

19.9

148

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

7.4

17.3

A28

ICPC

Limited function/disability NOS

2.7

12.8

456

M89.6

ICD-10 Finland

Osteopathy after poliomyelitis

+∞

11.5

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.7

10.6

316

S72.4

ICD-10 Finland

Fracture of lower end of femur

20.8

8.5

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.4

8.4

315

Z02.7

ICD-10 Finland

Issue of medical certificate

3.5

8.3

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.7

8.2

204

N18

ICPC

Paralysis/weakness

6.4

8.0

R5110, ,

SPAT

3.1

7.8

119

XG466

NOMESCO Finland

Sleep oxymetry

4.7

7.8

N03AX16

ATC

[U] pregabalin

2.2

7.4

434

M41.9

ICD-10 Finland

Scoliosis, unspecified

9.7

6.9

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.1

6.6

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.8

6.3

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.6

6.2

160

S82.1

ICD-10 Finland

Fracture of upper end of tibia

8.0

6.2

N03AE01

ATC

clonazepam; systemic

3.3

6.2

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

130

934

1.72

4.76

2.5

2.2

79.65

78.63

nmol/l

0.15

114

813

(3024561) Albumin [Mass/volume] in Serum or Plasma

144

1073

1.69

4.54

5.6

4.4

33.50

34.90

g/l

1.87

131

997

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

139

2.21

3.58

8.4

9.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

292

1.82

3.32

5.0

4.1

19.98

43.96

ug/l

0.36

255

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

488

1.67

3.31

3.5

3.9

176.53

161.93

ng/l

0.04

424

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

143

1129

1.53

3.16

6.8

5.8

1.21

mmol/l

0.11

131

1017

(3003396) Base excess in Arterial blood by calculation

316

1.75

3.03

6.3

6.8

2.07

1.14

mmol/l

1.15

256

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

154

1245

1.51

2.99

8.8

6.4

1.22

1.21

mmol/l

0.60

134

1062

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

6.10

2.71

1.0

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

318

1.69

2.71

6.4

6.7

5.32

5.03

kpa

1.65

305

(3027801) Oxygen [Partial pressure] in Arterial blood

318

1.69

2.71

6.4

6.7

11.66

kpa

0.00

306

(3021960) Folate [Moles/volume] in Serum or Plasma

616

1.54

2.71

1.6

18.82

20.19

nmol/l

0.43

510

(36660697) Celiac disease serology panel - Serum

134

2.03

2.70

1.2

—

(3000991) Gas panel - Venous blood

211

1.81

2.58

7.5

—

(40758558) Short blood count panel - Blood

552

1.51

2.37

7.1

6.8

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

129

1044

1.43

2.30

2.2

2.0

90.16

91.66

pmol/l

0.12

534

(3035637) Corticotropin [Mass/volume] in Plasma

3.55

2.28

1.6

1.5

—

(3018418) pH of Serum or Plasma

767

1.44

2.22

5.0

4.1

7.41

7.40

0.27

138

(3023368) Bacteria identified in Blood by Culture

742

1.44

2.17

3.8

4.2

—

(3052851) Hemolysis interference index of Serum or Plasma

2.09

2.00

2.8

3.9

—

(3022217) INR in Platelet poor plasma by Coagulation assay

146

1236

1.37

1.88

10.9

16.7

1.31

inr

0.03

344

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

138

1.81

1.86

5.8

6.3

25.73

24.62

mmol/l

0.85

138

(3051593) INR in Capillary blood by Coagulation assay

4.22

1.83

4.2

18.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

1.72

0.0

1.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

181

1.67

1.71

4.2

3.2

119.06

82.79

ng/l

0.79

159

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

150

1.73

1.70

2.6

2.9

2.15

1.92

mmol/l

0.17

114

(3044290) Cell count panel - Cerebral spinal fluid

2.55

1.68

1.2

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

510

1.41

1.61

4.5

3.1

2.48

2.46

mmol/l

0.78

447

(3051611) Lipemic interference index of Serum or Plasma

2.54

1.61

2.4

3.4

—

(3002032) Base excess in Venous blood by calculation

234

1.56

1.59

3.9

3.4

2.53

2.06

mmol/l

0.44

188

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

197

1774

1.36

1.58

8.1

7.7

82.34

79.45

u/l

0.29

182

1654

(3024928) Oxygen saturation in Venous blood

2.16

1.46

2.1

2.4

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

350

1.45

1.46

2.5

2.2

2.24

2.27

g/l

0.09

319

(3015377) Calcium [Moles/volume] in Serum or Plasma

100

827

1.32

1.42

4.6

3.2

2.35

mmol/l

0.09

720

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

622

1.35

1.41

2.6

2.0

2.73

3.27

mg/l

1.26

533

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

1.35

0.0

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

1.35

0.0

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

1.35

0.0

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

2.17

1.35

1.2

—

(1616796) Gas panel - Central venous blood

2.08

1.28

2.8

3.8

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

142

1244

1.28

7.1

6.4

10.74

11.76

umol/l

0.71

134

1176

(3022096) Basophils/100 leukocytes in Blood

113

962

1.29

1.27

5.1

5.7

0.65

0.62

0.25

106

892

(3002256) Pathology report gross observation

273

1.45

1.26

1.2

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2.26

1.25

1.0

1.3

—

(3019060) Gas panel - Arterial blood

189

1.53

1.24

4.7

4.3

—

(3002030) Lymphocytes/100 leukocytes in Blood

118

1013

1.28

1.24

5.9

25.92

26.00

0.02

110

939

(3042111) Morphology [Interpretation] in Bone marrow Narrative

2.00

1.23

1.3

1.8

—

(3021788) Differential panel - Synovial fluid

2.19

1.22

1.3

1.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

2.33

1.19

1.2

2.4

20.83

76.68

u/ml

—

(3006504) Eosinophils/100 leukocytes in Blood

115

990

1.27

1.17

5.9

5.6

3.10

2.78

0.60

108

918

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

2.53

1.15

1.0

—

(3018095) Leukocytes [#/volume] in Urine

102

868

1.27

1.13

5.1

4.1

827.18

103.73

e6/l

0.55

640

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

2.37

1.13

1.0

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

2.00

1.12

1.0

1.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

2.00

1.12

1.0

1.5

—

(3019069) Monocytes/100 leukocytes in Blood

115

995

1.26

1.11

7.0

6.0

8.60

8.76

0.22

107

925

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

415

1.34

1.08

1.3

1.2

17.08

0.96

u/ml

—

112

(1761868) Lipid panel - Serum or Plasma

588

0.74

1.07

3.1

3.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

144

1595

0.80

1.05

3.8

15.50

15.10

pmol/l

1.09

132

1391

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

593

1.29

1.03

1.5

1.6

1.26

1.29

mmol/l

0.11

489

(3037467) Urinalysis macro (dipstick) panel - Urine

174

1589

1.24

1.01

5.0

4.7

—

(4200892) Spirometry reversibility

165

1.50

1.00

1.3

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

420

1.32

1.00

4.2

3.2

3.44

1.92

e6/l

0.34

238

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

182

1.47

1.00

2.0

1.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

531

1.29

0.99

1.9

1.7

1181.59

1171.05

nmol/l

0.03

400

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

430

1.32

0.99

2.0

1.9

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.98

0.0

1.7

—

(3000492) Spirometry study

172

0.57

0.97

1.7

1.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.95

0.0

1.6

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

2.25

0.94

1.7

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

300

0.68

0.94

8.7

7.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

380

1.32

0.92

1.5

2.62

2.66

g/l

0.04

210

(3042936) Bacteria identified in Isolate by Culture

362

1.32

0.92

2.2

1.9

—

(3044927) Protein electrophoresis panel - Urine

2.17

0.92

1.3

1.1

—

(3044941) Cell count panel - Synovial fluid

2.17

0.92

1.2

1.3

—

(3017181) Myelocytes/100 leukocytes in Blood

193

0.61

0.91

2.9

4.3

1.57

0.93

—

(3018010) Neutrophils/100 leukocytes in Blood

114

1004

1.23

0.91

5.8

5.6

58.27

58.52

0.07

105

935

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

2.09

0.90

1.0

1.4

1.08

0.54

nmol/l

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

103

1.59

0.89

2.4

2.0

394.14

327.20

ug/l

0.14

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

717

1.24

0.89

2.7

2.3

57.80

64.47

u/l

0.43

667

(3001122) Ferritin [Mass/volume] in Serum or Plasma

100

870

1.23

0.89

3.0

2.5

132.55

143.64

ug/l

0.21

779

(3013826) Glucose [Moles/volume] in Serum or Plasma

154

1400

1.22

0.89

5.8

4.9

7.08

6.86

mmol/l

0.54

144

1314

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

337

1.32

0.89

2.8

2.2

20.84

21.74

0.20

289

(3021440) Promyelocytes/100 leukocytes in Blood

179

0.60

0.88

2.8

4.4

0.00

0.14

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

293

1.34

0.87

2.0

1.8

—

(3021901) Oxygen saturation in Capillary blood

1.84

0.86

2.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1.70

0.86

1.5

1.7

—

132.00

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1.65

0.86

2.0

2.1

0.28

0.34

u/ml

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1.78

0.84

1.2

1.1

555.30

496.29

mg/l

—

(3013512) EKG study

759

0.80

0.84

3.9

4.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1.89

0.82

1.0

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

1.89

0.82

2.8

3.2

58.83

60.44

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1.89

0.82

1.0

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.61

0.79

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.79

0.0

1.1

—

4.45

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.79

0.0

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.79

0.0

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.79

0.0

1.8

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.76

0.0

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

437

1.26

0.76

3.9

2.9

0.77

0.95

e6/l

0.26

252

(3026008) Bacteria identified in Urine by Culture

825

1.21

0.76

3.8

3.5

—

(3044640) Blood type and Crossmatch panel - Blood

758

1.21

0.76

2.3

2.6

—

(3025159) Blasts/100 leukocytes in Blood

171

0.63

0.74

3.1

4.4

0.00

0.17

—

(3002582) Erythrocytes [#/volume] in Urine

779

1.21

0.74

4.7

3.5

67.83

145.13

e6/l

0.40

603

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

2.02

0.73

1.2

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

2.02

0.73

1.0

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1.81

0.73

1.1

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

1.60

0.72

5.0

6.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1.77

0.72

1.0

1.9

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

188

1992

0.84

0.71

3.8

4.3

1.27

1.24

mmol/l

0.30

169

1764

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

686

1.21

0.71

3.4

39.32

31.75

u/l

0.86

655

(3022313) Gas panel - Capillary blood

118

1.47

0.71

3.1

2.9

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

225

2147

1.22

0.69

20.4

17.1

29.46

26.14

mg/l

0.77

191

1755

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1.87

0.68

1.0

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

296

1.29

0.68

1.9

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.80

0.66

1.8

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.80

0.66

2.0

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

252

1.30

0.66

3.5

3.8

—

(36304419) Bacteria [Presence] in Urine

673

1.20

0.65

4.1

3.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1.74

0.64

1.2

1.1

152.00

388.50

u/ml

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

852

0.84

0.63

4.2

4.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1.65

0.62

1.9

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

109

985

1.17

0.62

5.8

6.3

—

(3013290) Carbon dioxide [Partial pressure] in Blood

1.62

0.62

3.0

4.7

5.30

5.06

kpa

—

(3027315) Oxygen [Partial pressure] in Blood

1.62

0.62

3.0

4.7

8.89

7.89

kpa

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1.68

0.61

1.2

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

1.68

0.61

3.0

2.4

3.80

5.34

e9/l

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

118

1075

1.17

0.61

2.3

2.7

—

(3037121) Protein [Mass/volume] in Urine

1.52

0.60

5.6

3.2

0.16

0.19

g/l

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1.52

0.60

4.1

5.4

—

2.85

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.60

0.0

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.60

0.0

4.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1.47

0.60

3.1

3.4

25.45

25.35

mmol/l

0.06

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.59

0.0

1.1

—

1.67

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.58

0.0

1.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

317

0.77

0.58

5.1

4.7

28.57

32.25

1.34

199

(3004716) Salmonella sp identified in Stool by Organism specific culture

0.55

0.57

1.0

1.3

—

(4034850) Laboratory test

0.55

0.57

12.8

10.1

—

(40768804) Tissue Pathology biopsy report

876

1.16

0.55

2.1

2.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

170

0.69

0.55

2.9

4.3

0.86

0.52

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1.52

0.55

3.4

3.0

0.91

0.93

nmol/l

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1.52

0.55

2.4

1.5

—

(3001604) Monocytes [#/volume] in Blood

116

1063

1.15

0.54

5.7

5.5

0.58

0.60

e9/l

0.39

918

(3007853) Bacteria identified in Skin by Aerobe culture

260

1.26

0.54

2.3

1.7

—

(3013115) Eosinophils [#/volume] in Blood

120

1103

1.15

0.54

6.0

5.7

0.19

e9/l

0.05

963

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1.47

0.53

1.2

—

4.42

—

(3019225) pH of Specimen

243

1.26

0.52

6.0

4.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

162

1.32

0.51

1.5

1.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

208

1.27

0.50

2.7

1.9

372.19

362.12

nmol/l

0.09

192

(3006315) Basophils [#/volume] in Blood

116

1069

1.14

0.50

5.7

5.5

0.04

e9/l

0.19

924

(3013707) Erythrocyte sedimentation rate by Westergren method

174

1648

1.14

0.49

4.1

4.4

16.49

14.14

mm/h

1.13

167

1495

(3000330) Specific gravity of Urine by Test strip

143

0.69

0.49

2.1

4.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

191

1994

0.87

0.47

4.7

4.6

1.75

2.04

mu/l

2.49

170

1747

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

183

1.28

0.46

1.4

—

(3022621) pH of Urine by Test strip

165

1.29

0.46

3.3

3.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1.44

0.46

1.9

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.44

0.46

1.4

1.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

157

1.29

0.45

1.5

1.7

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

134

1256

1.13

0.43

9.4

9.2

4.28

4.23

e9/l

0.06

110

1098

(3000850) Epithelial cells [#/volume] in Urine

543

1.16

0.42

3.3

2.7

4.76

4.37

e6/l

0.15

489

(21494434) Karyotype in Bone marrow

1.57

0.42

1.2

1.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

609

0.86

0.42

2.8

3.0

8405.62

7113.85

umol/l

0.06

506

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1.44

0.42

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

746

1.14

0.42

4.0

3.1

6.38

7.07

mmol/l

0.92

607

(3009214) Lutropin [Units/volume] in Serum or Plasma

1.52

0.41

1.8

1.2

4.18

9.55

u/l

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

207

2142

0.88

0.41

4.9

5.1

6.16

6.14

mmol/l

0.09

185

1910

(40768800) Prostate Pathology biopsy report

1.37

0.41

1.0

1.1

—

(3024263) Appearance of Synovial fluid

0.00

0.41

0.0

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.4

—

(3020491) Glucose [Moles/volume] in Blood

0.00

0.41

0.0

2.6

—

7.21

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

0.00

0.41

0.0

3.4

—

23.18

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

160

0.74

0.41

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.41

0.0

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.41

0.0

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

317

1.19

0.40

2.4

2.8

1.63

1.78

0.60

282

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

101

0.69

0.40

1.3

2.4

4.36

4.30

pmol/l

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.40

0.0

1.2

—

(3045716) Anion gap in Serum or Plasma

0.00

0.40

0.0

2.1

—

8.88

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.40

0.0

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.40

0.0

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.40

0.0

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.40

0.0

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.40

0.0

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

190

1823

1.13

0.40

24.7

20.5

15.03

15.48

0.60

185

1792

(3010421) pH of Blood

1.32

0.40

3.1

4.2

7.43

7.41

—

(3025941) Bacteria identified in Stool by Culture

115

0.69

0.37

1.1

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

199

2059

0.89

0.37

4.3

4.8

1.45

1.47

mmol/l

0.24

181

1833

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

1.47

0.36

3.5

2.8

16.33

33.65

u/ml

—

(3030467) Casts [#/volume] in Urine by Automated count

715

1.13

0.36

4.2

3.4

0.32

0.57

e6/l

0.73

540

(3019230) Fractional oxyhemoglobin in Venous blood

1.40

0.35

1.0

1.9

46.83

59.71

—

(3019198) Lymphocytes [#/volume] in Blood

116

1089

1.11

0.35

5.7

5.5

1.66

1.89

e9/l

1.10

971

(3015736) pH of Urine

853

1.12

0.35

3.0

4.0

—

5.89

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1.38

0.35

1.6

—

(3021589) Normoblasts [#/volume] in Blood

103

962

1.11

0.34

9.4

10.3

0.00

e9/l

0.59

797

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

533

1.13

0.34

1.9

1.8

444.52

433.87

pmol/l

0.11

438

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.34

0.34

1.5

1.2

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

915

1.11

0.33

4.4

3.3

—

(3023520) Reticulocytes [#/volume] in Blood

230

1.19

0.32

3.0

2.9

67.56

68.78

e9/l

0.04

182

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

202

2080

0.90

0.31

4.4

4.8

4.44

4.47

mmol/l

0.19

185

1865

(3044889) 12 lead EKG panel

165

1586

1.10

0.30

3.9

4.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

531

0.88

0.29

2.6

3.2

0.96

0.81

ug/l

0.64

386

(3003694) ABO and Rh group [Type] in Blood

539

1.12

0.29

1.3

—

(3037756) Immunofixation for Serum or Plasma

1.28

0.28

3.8

1.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

187

1.19

0.27

4.2

3.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

580

1.11

0.27

2.5

2.4

—

(3049717) Cytology report of Urine Cyto stain

122

1.24

0.27

3.5

2.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.27

0.26

2.0

1.6

—

(3000494) Fungus identified in Specimen by Culture

277

0.85

0.26

1.8

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.69

0.26

1.0

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.69

0.26

1.0

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

609

0.90

0.26

4.5

4.4

0.00

estimate

-0.00

201

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

742

0.91

0.26

3.6

4.6

24.22

21.55

0.72

393

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

128

1222

1.09

0.26

3.3

52.77

54.68

u/l

0.09

114

1116

(3011397) Hemoglobin [Presence] in Urine by Test strip

524

1.11

0.25

3.6

3.9

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

210

2150

0.91

0.25

5.0

5.5

2.61

2.58

mmol/l

0.14

190

1915

(3022145) Colonoscopy Study observation

265

0.86

0.25

1.8

1.3

—

(40768797) Stomach Pathology biopsy report

313

1.13

0.24

1.3

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

199

1.17

0.24

1.6

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

0.73

0.22

1.1

1.2

54.59

200.06

u/ml

—

(3000012) Reticulocyte production index

1.25

0.22

3.2

2.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.00

0.21

0.0

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

3.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

0.21

0.0

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

4.7

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.00

0.21

0.0

1.3

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

0.21

0.0

1.1

—

8.40

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.00

0.21

0.0

7.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.00

0.21

0.0

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.9

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.9

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

189.00

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1.17

0.21

1.0

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.9

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.9

—

(3028433) Virus identified in Specimen by Culture

0.00

0.20

0.0

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

0.20

0.0

1.1

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.20

0.20

1.0

1.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

484

1.09

0.19

1.5

1.7

1.10

1.48

mg/l

0.86

382

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

759

1.07

0.19

2.6

2.1

509.71

235.89

u/l

0.40

709

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

132

0.83

0.18

2.2

2.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

922

0.93

0.18

4.7

5.2

5.16

2.95

ug/l

0.33

811

(3035350) Ketones [Presence] in Urine by Test strip

114

1097

1.07

0.18

3.5

4.2

0.00

estimate

-0.00

228

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1.13

0.17

1.1

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

0.75

0.17

1.0

1.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.74

0.17

1.0

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

114

1099

1.06

0.17

4.6

5.7

0.00

estimate

-0.00

211

(3048689) Calprotectin [Mass/mass] in Stool

225

0.88

0.17

2.7

2.0

262.07

149.58

ug/g

0.48

182

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.71

0.17

1.0

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1.16

0.16

1.3

1.5

186.50

273.59

ug/g

—

(40761535) Cells panel - Urine sediment

214

0.88

0.16

2.9

3.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

233

2298

1.08

0.15

23.6

20.0

139.01

139.63

mmol/l

2.16

226

2233

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

129

0.85

0.15

1.5

2.4

1.25

1.09

0.35

129

(3020961) Endomysium IgA Ab [Titer] in Serum

0.78

0.14

1.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

208

1.12

0.14

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

591

0.93

0.14

3.3

4.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

233

2301

1.07

0.13

24.1

20.0

3.95

4.01

mmol/l

1.75

226

2235

(40761511) CBC panel - Blood by Automated count

224

2212

1.06

0.12

16.9

16.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

116

0.86

0.12

1.6

1.3

—

54.94

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

188

0.90

0.11

1.4

1.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

125

0.88

0.10

1.5

2.4

0.61

0.66

0.16

125

(3024731) MCV [Entitic volume]

236

2337

1.06

0.10

28.0

24.8

91.26

91.76

0.80

228

2297

(3007461) Platelets [#/volume] in Blood

236

2337

1.06

0.10

27.6

24.9

255.78

240.27

e9/l

2.57

223

2270

(3010813) Leukocytes [#/volume] in Blood

236

2337

1.06

0.10

28.0

24.9

7.08

6.91

e9/l

0.45

224

2255

(3035941) MCH [Entitic mass]

236

2337

1.06

0.10

27.9

24.8

30.14

30.44

1.48

228

2297

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

106

1.14

0.10

2.2

1.8

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

319

0.93

0.09

1.1

1.3

13.78

50.07

iu/ml

—

106

(3026361) Erythrocytes [#/volume] in Blood

236

2338

1.05

0.09

28.1

24.9

4.33

4.40

e12/l

1.32

223

2256

(3009542) Hematocrit [Volume Fraction] of Blood

236

2338

1.05

0.09

28.4

25.0

38.37

39.53

1.61

206

2166

(3000963) Hemoglobin [Mass/volume] in Blood

236

2338

1.05

0.09

28.1

25.0

129.59

133.15

g/l

2.83

228

2294

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

0.82

0.08

1.8

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.14

0.08

1.2

1.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

967

1.04

0.08

2.5

2.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

127

1.11

0.08

1.1

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.85

0.07

1.3

1.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

230

2281

1.04

0.07

24.0

20.4

71.93

81.77

umol/l

3.33

230

2281

(3045414) Leukocytes [Presence] in Urine

1.04

0.07

1.8

2.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

0.85

0.07

1.8

3.4

—

(40768443) Skin Pathology biopsy report

101

0.89

0.06

1.3

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

109

1.11

0.06

2.0

2.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

203

2048

0.97

0.06

21.3

16.3

82.19

73.02

ml/min/173m2

5.98

159

1680

(3009261) Glucose [Presence] in Urine by Test strip

113

1111

1.03

0.06

3.5

4.3

0.00

estimate

-0.00

200

(4035726) Immunohistochemistry procedure

218

1.06

0.05

1.7

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

205

2065

0.97

0.04

6.2

6.5

40.42

41.00

mmol/mol

0.36

184

1889

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

865

0.98

0.04

2.3

3.1

1258.69

1753.63

ng/l

0.54

749

(3019150) Specific gravity of Urine by Refractometry

487

1.03

0.04

4.3

4.7

1.02

kg/l

0.40

(3026782) Osmolality of Urine

537

1.03

0.04

3.0

3.3

541.84

550.00

mosm/kgh2o

0.13

459

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

100

1013

0.98

0.03

3.3

4.3

71.71

46.50

ng/l

0.38

802

(3020682) Albumin/Creatinine [Ratio] in Urine

789

1.02

0.02

4.8

3.7

21.18

9.24

mg/mmol

0.56

492

(3012516) Albumin [Mass/volume] in Urine

742

1.01

0.01

4.2

3.2

106.67

141.22

mg/l

0.14

484

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

228

2273

1.02

0.01

11.7

11.4

26.93

24.27

u/l

1.06

219

2172

(3020891) Body temperature

1.02

0.00

2.2

4.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

122

0.98

0.00

1.6

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

179

1.01

0.00

4.4

3.2

68.25

58.19

ml/min/173m2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

209

1.01

0.00

1.4

—

(40761536) Microorganisms panel - Urine sediment

183

0.98

0.00

4.6

4.0

—

(3037522) Nuclear Ab [Titer] in Serum

244

0.98

0.00

1.3

253.33

526.32

titre

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.0

—

146.40

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

1.9

—

109.88

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

0.0

1.3

—

1055.29

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.0

3.4

—

(3003129) Base excess in Capillary blood by calculation

0.00

0.0

1.1

—

3.80

—

(3020650) Glucose [Presence] in Urine

0.00

0.0

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.0

1.1

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

0.00

0.0

2.6

—

32041.00

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.00

0.0

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.0

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

0.0

1.5

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

0.89

0.00

2.6

0.00

g/l

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

0.00

0.0

3.2

—

0.64

—

(40757373) Influenza virus identified in Isolate

0.00

0.0

1.4

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.0

1.8

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

0.88

0.00

2.6

0.00

g/l

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

0.00

0.0

3.2

—

1.06

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.0

1.0

—

(3014891) Appearance of Pleural fluid

0.00

0.0

1.3

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

0.00

0.0

1.0

—

20.80

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.0

1.6

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.00

0.0

1.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.7

—

23.11

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.7

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

0.00

-0.00

0.0

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

1.63

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

-0.00

0.0

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.3

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1.00

-0.00

2.3

2.6

1.87

0.85

g/l

—

(3015183) Erythrocyte sedimentation rate

0.00

-0.00

0.0

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.3

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

3.8

—

52.83

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.2

—

(3000285) Sodium [Moles/volume] in Blood

0.00

-0.00

0.0

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

0.97

-0.00

2.4

2.5

0.00

g/l

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.02

-0.00

1.3

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

0.96

-0.00

1.2

—

2.58

—

(3014051) Protein [Presence] in Urine by Test strip

0.92

-0.00

2.2

3.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3006462) Nitrate [Presence] in Urine

0.00

-0.00

0.0

6.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_SEQULAE_POLIO and mortality.

Females

Parameter	HR [95% CI]	p-value
AB1_SEQULAE_POLIO	1.391 [1.15, 1.68]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.261

During the follow-up period (1.1.1998 — 31.12.2019), 218 out of 652 females with AB1_SEQULAE_POLIO died.

Males

Parameter	HR [95% CI]	p-value
AB1_SEQULAE_POLIO	1.694 [1.4, 2.05]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.01

During the follow-up period (1.1.1998 — 31.12.2019), 273 out of 623 males with AB1_SEQULAE_POLIO died.

Mortality risk

Mortality risk for people of age

years, who have AB1_SEQULAE_POLIO.

N-year risk	Females	Males
1	0.116%	0.295%
5	0.895%	1.986%
10	2.244%	4.869%
15	4.346%	9.197%
20	7.669%	15.654%

Relationships between endpoints

↥

Index endpoint: AB1_SEQULAE_POLIO – Sequelae of poliomyelitis

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Sequelae of poliomyelitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints